|
Table S4.4 Klebsiella pneumoniae resistance, by specimen source, 2014
|
| səhifə | 10/26 | | tarix | 12.02.2017 | | ölçüsü | 388,53 Kb. | | #8296 |
|
Antimicrobial
|
Blood, % resistant (n)
|
Urine, % resistant (n)
|
Other, % resistant (n)
|
Total, % resistant (n)
|
Ampicillin
|
96.7 (1 449)
|
98.7 (10 587)
|
98.5 (1 088)
|
98.5 (13 124)
|
Amoxicillin–clavulanate
|
9.4 (1 358)
|
4.7 (10 647)
|
6.6 (908)
|
5.3 (12 913)
|
Ticarcillin–clavulanate
|
11.3 (959)
|
28.1 (608)
|
23.1 (104)
|
18.1 (1 671)
|
Piperacillin–tazobactam
|
7.6 (1 454)
|
8.9 (4 145)
|
8.9 (973)
|
8.6 (6 572)
|
Cefazolin
|
10.6 (1 144)
|
6.6 (4 298)
|
9.2 (1 099)
|
7.7 (6 541)
|
Cefoxitin
|
na
|
3.4 (6 171)
|
na
|
3.4 (6 171)
|
Ceftriaxone
|
6.6 (1 445)
|
4.3 (4 811)
|
6.1 (990)
|
5.0 (7 246)
|
Ceftazidime
|
5.8 (875)
|
na
|
na
|
5.8 (875)
|
Cefepime
|
3.1 (970)
|
na
|
na
|
3.1 (870)
|
Trimethoprim
|
16.6 (875)
|
12.3 (10 582)
|
na
|
12.7 (11 457)
|
Trimethoprim–sulfamethoxazole
|
14.0 (1 447)
|
8.2 (4 285)
|
8.0 (1 089)
|
9.4 (6 821)
|
Gentamicin
|
4.6 (1 448)
|
3.1 (4 961)
|
4.9 (1 088)
|
3.6 (7 497)
|
Tobramycin
|
6.4 (970)
|
6.4 (610)
|
19.4 (103)
|
7.2 (1 683)
|
Amikacin
|
0.9 (875)
|
na
|
na
|
0.9 (875)
|
Ciprofloxacin
|
4.5 (1 449)
|
4.5 (4 145)
|
6.2 (964)
|
4.7 (6 558)
|
Norfloxacin
|
12.6 (875)
|
5.6 (10 422)
|
na
|
6.2 (11 297)
|
Nitrofurantoin
|
34.6 (875)
|
21.0 (6 209)
|
na
|
22.7 (7 084)
|
Meropenem
|
0.5 (1 443)
|
0.1 (4 136)
|
0.0 (972)
|
0.2 (6 551)
|
na = not available (either not tested or tested against an inadequate number of isolates)
Sources: OrgTRx (Queensland); AGAR (national); SNP (Queensland and northern New South Wales)
Table S4.5 Enterobacter cloacae resistance, by specimen source, 2014
Antimicrobial
|
Blood, % resistant (n)
|
Other, % resistant (n)
|
Total, % resistant (n)
|
Ampicillin
|
89.4 (405)
|
99.9 (1920)
|
98.1 (2325)
|
Amoxicillin–clavulanate
|
90.9 (340)
|
99.7 (1543)
|
98.1 (1883)
|
Ticarcillin–clavulanate
|
28.5 (404)
|
50.3 (596)
|
41.5 (1000)
|
Piperacillin–tazobactam
|
24.3 (382)
|
32.2 (199)
|
27.0 (581)
|
Cefazolin
|
97.6 (292)
|
100.0 (380)
|
99.0 (672)
|
Cefoxitin
|
na
|
99.5 (1541)
|
99.5 (1541)
|
Ceftriaxone
|
24.2 (567)
|
26.3 (2625)
|
25.9 (3192)
|
Ceftazidime
|
24.4 (340)
|
na
|
24.4 (340)
|
Cefepime
|
3.2 (403)
|
na
|
3.0 (403)
|
Trimethoprim
|
18.3 (338)
|
21.3 (2773)
|
21.0 (3111)
|
Trimethoprim–sulfamethoxazole
|
19.9 (569)
|
17.6 (2467)
|
18.0 (3036)
|
Gentamicin
|
7.2 (568)
|
7.6 (2843)
|
7.6 (3411)
|
Tobramycin
|
7.2 (405)
|
11.1 (692)
|
9.7 (1097)
|
Amikacin
|
0.0 (340)
|
na
|
0.0 (340)
|
Ciprofloxacin
|
4.7 (571)
|
4.4 (2361)
|
4.5 (2932)
|
Norfloxacin
|
11.5 (340)
|
6.4 (2731)
|
6.9 (3071)
|
Nitrofurantoin
|
21.8 (339)
|
35.1 (1548)
|
32.8 (1887)
|
Meropenem
|
2.6 (571)
|
1.3 (2399)
|
1.5 (2970)
|
na = not available (either not tested or tested against an inadequate number of isolates)
Sources: OrgTRx (Queensland); AGAR (national); SNP (Queensland and northern New South Wales)
Dostları ilə paylaş: |
|
|
